Novel prenatally diagnosed compound heterozygous PXDN variants in fetal congenital primary aphakia and blepharophimosis.

Blepharophimosis Chromosome microarray analysis (CMA) Compound heterozygous Congenital primary aphakia Whole exon sequencing (WES)

Journal

Taiwanese journal of obstetrics & gynecology
ISSN: 1875-6263
Titre abrégé: Taiwan J Obstet Gynecol
Pays: China (Republic : 1949- )
ID NLM: 101213819

Informations de publication

Date de publication:
May 2022
Historique:
accepted: 20 07 2021
entrez: 20 5 2022
pubmed: 21 5 2022
medline: 25 5 2022
Statut: ppublish

Résumé

To precision survey a fetal congenital primary aphakia molecular etiology. A case of 42 years old pregnancy woman prenatal diagnostic examination by amniocentesis conducted at 17 weeks' gestation and demonstrated a normal female karyotype. Trio studies based on chromosome microarray analysis (CMA) and Sanger's genetic analysis did not detect a pathologic variant of the FOXE3 gene. Fetal congenital primary aphakia accompanied with microphthalmia detected by sonography in the second trimester (22 weeks). MRI indicated bilateral absence of the lenses, consistent with primary congenital aphakia. Due to the poor prognosis of congenital aphakia, the parents decided to terminate the fetus and provided consent for an autopsy. Pathological analysis revealed dysplasia of the anterior segment of both eyes. However, post fetal mortem extended trio whole exon sequencing (WES) and Sanger's genetic analysis identified compound heterozygous variants in the chromosomal location 2p25.3 in the PXDN gene. Extended whole exon sequencing is an important tool to study primary congenital aphakia.

Identifiants

pubmed: 35595447
pii: S1028-4559(22)00087-0
doi: 10.1016/j.tjog.2022.03.019
pii:
doi:

Substances chimiques

Deoxyribonucleosides 0
Purine Nucleosides 0
5'-O-(9-phenylxanthen-9-yl)-2'-deoxynebularine 114155-96-3

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

510-513

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no conflicts of interest.

Auteurs

Wei Shin Chou (WS)

Department of Obstetrics and Gynecology, Taipei City Hospital, Women and Children Campus, Taiwan.

Yu Ming Shiao (YM)

Department of Bioscience Technology, Chung Yuan Christian University, Taiwan; Union Clinical Laboratory, Taiwan.

Jia Shing Chen (JS)

School of Medicine for International Students, I-Shou University, Kaohsiung, Taiwan.

Ju Chin Tsauer (JC)

Department of Obstetrics and Gynecology, Taipei City Hospital, Women and Children Campus, Taiwan.

Yi Fen Chang (YF)

Department of Obstetrics and Gynecology, Taipei City Hospital, Women and Children Campus, Taiwan.

Yen-Hui Chiu (YH)

Union Clinical Laboratory, Taiwan.

Ching Hua Hsiao (CH)

Department of Obstetrics and Gynecology, Taipei City Hospital, Women and Children Campus, Taiwan; Department of Biomedical Engineering, National Yang Ming Chiao Tung University - Yang Ming Campus, Taiwan. Electronic address: hsiaochh2866@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH